B6;129-Elovl4/J
TECHNOLOGY NUMBER: 2022-244
Technology No. 2022-244
1
INNOVATION
This Elovl4del targeted mutation strain exhibits homozygous perinatal lethality, defective epidermal permeability barrier, and progressive retinal photoreceptor degeneration, and is useful in studies of Stargardt-like macular degeneration and progressive retinal degeneration.